Trustar Capital
Lower valuations, less leverage could drive China PE returns - HKMA Forum
China private equity could deliver some strong vintages relative to other markets given falling valuations, a deepening pool of management talent, and a historical emphasis on driving returns through growth rather than leverage, industry participants...
Trustar, Bain, BPEA EQT target Tyson Foods' China poultry business
US-based meat and processed food maker Tyson Foods has received preliminary bids from private equity firms including Trustar Capital, Bain Capital and BPEA EQT for its China poultry business, according to two sources familiar with the matter.
China GPs seek global angles as domestic deployment slows - AVCJ Forum
Global expansion remains a bright spot in China’s investment landscape as private equity firms slow deployment domestically in favour of supporting China-related entrepreneurs or business concepts in other markets, the AVCJ Private Equity & Venture...
Carlyle, Trustar pursue partial exit, rollover of McDonald's China
The Carlyle Group and Trustar Capital, private equity owners of McDonald’s China, are poised to abandon plans for a single asset continuation fund in favour of exiting part of their holdings and rolling over the rest into other funds.
Deal focus: Patience pays off for Trustar on Moritex
Trustar Capital’s 20x return on Japanese precision manufacturing business Moritex was driven by greater geographic diversification in production and distribution and a shakeup of the product portfolio
Trustar exits Japan's Moritex via $275m trade sale
Trustar Capital has sold Japanese machine vision lenses maker Moritex Corporation to a strategic buyer for about USD 275m after a nearly nine-year hold.
The innovation game: China GPs play safe
China investors have abandoned their previous high-risk-high-return approach in favour of proven business models and profitability. Hotspots like autonomous driving, biotech, and SaaS are no exception
Japanese GPs maintain strong investment pace - AVCJ Forum
Deployment remains robust in Japan’s mid-cap space with private equity firms continuing to see plentiful opportunities in carve-outs and founder-succession situations, the AVCJ Private Equity & Venture Forum Japan 2023 heard.
China: Who’s investing?
Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles
Chinese investors sell international assets of condom maker LifeStyles
A Chinese investor group featuring several private equity firms has sold the non-China assets of LifeStyles Healthcare, a global sexual health and wellness platform best known for the Lifestyles condom brand, to US-based Linden Capital Partners.
Portfolio: Trustar Capital and Trustlink
Through Trustlink, Trustar Capital has successfully executed a buy-and-build strategy in China’s facility management space, using scale and standardisation to win contracts from multinationals
Sport investment: China fading
Once a white-hot investment theme in China, and for Chinese investors looking overseas, sport has slipped into obscurity amid concerns about regulation and monetisation
Investors endorse 'long Chinese' thesis - AVCJ webinar
The shift from “long China” to “long Chinese,” which has gained traction as a soundbite as investors look to back local entrepreneurs in overseas markets, was highlighted once again during AVCJ’s China Private Markets Outlook webinar.
Energy transition case study: Axilone
Energy accounts for a relatively small portion of cosmetics packaging producer Axilone’s overall costs, but rising prices in Europe prompted owner Trustar Capital to accelerate transition efforts
Trustar seeks $3.5b for fifth China buyout fund
Trustar Capital, formerly known as CITIC Capital Partners, is looking to raise USD 3.5bn for its fifth China buyout fund and USD 250m for a debut growth vehicle.
Trustar buys China condiments supplier
Trustar Capital, formerly known as CITIC Capital Partners, has acquired China-based food condiments supplier Beijing Salion Foods for an undisclosed sum.
AVCJ Awards 2021: Deal of the Year – Large Cap: China Biologic
For Centurium Capital, China Biologic was no ordinary take-private. It was the culmination of a multi-year effort to tighten the company’s shareholding structure and root out management inefficiencies
Energy transition to dominate private equity – AVCJ Forum
Energy transition, including innovation in power and transportation, will be the biggest investment theme in the decades to come, industry veterans told the AVCJ Private Equity & Venture Forum.
China's Trustar buys European EV charging specialist
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
China education: Opportunity erased?
Private equity investors have pumped billions of dollars into Chinese online education platforms, notably in the K-12 space. A regulatory crackdown has left them wondering how they can get their money back